ApoE ε4 has been shown to accumulate along with the deposition of β amyloid, and it promotes α-synuclein aggregation, thus being associated with the severity of Lewy body pathology (71, 72), which may be the molecular mechanisms of worsening cognitive function in ApoE ε4 carriers of PD patients. The gene discussed is APOE; the disease is Parkinson disease.